This is an academic paper showing that treating pregnant women with opioid use disorder (OUD) via telemedicine was just as effective as in-person treatment when measuring rates of treatment retention and neonatal abstinence syndrome (NAS), even though the sample size was small (n = 98) and the study did not use randomization.
Guille, C., Simpson, A.N., Douglas, E., et al. (2020). Treatment of Opioid Use Disorder in Pregnant Women via Telemedicine: A Nonrandomized Controlled Trial. JAMA Open Network, 3(1), e1920177.